Circulating relaxin acts on subfornical organ neurons to stimulate water drinking in the rat.
Relaxin, a peptide hormone secreted by the corpus luteum during pregnancy, exerts actions on reproductive tissues such as the pubic symphysis, uterus, and cervix. It may also influence body fluid balance by actions on the brain to stimulate thirst and vasopressin secretion. We mapped the sites in the brain that are activated by i.v. infusion of a dipsogenic dose of relaxin (25 microg/h) by immunohistochemically detecting Fos expression. Relaxin administration resulted in increased Fos expression in the subfornical organ (SFO), organum vasculosum of the lamina terminalis (OVLT), median preoptic nucleus, and magnocellular neurons in the supraoptic and paraventricular nuclei. Ablation of the SFO abolished relaxin-induced water drinking, but did not prevent increased Fos expression in the OVLT, supraoptic or paraventricular nuclei. Although ablation of the OVLT did not inhibit relaxin-induced drinking, it did cause a large reduction in Fos expression in the supraoptic nucleus and posterior magnocellular subdivision of the paraventricular nucleus. In vitro single-unit recording of electrical activity of neurons in isolated slices of the SFO showed that relaxin (10(-7) M) added to the perfusion medium caused marked and prolonged increase in neuronal activity. Most of these neurons also responded to 10(-7) M angiotensin II. The data indicate that blood-borne relaxin can directly stimulate neurons in the SFO to initiate water drinking. It is likely that circulating relaxin also stimulates neurons in the OVLT that influence vasopressin secretion. These two circumventricular organs that lack a blood-brain barrier may have regulatory influences on fluid balance during pregnancy in rats.
Sunn
N
N
Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Victoria 3010, Australia.
Egli
M
M
Burazin
T C D
TC
Burns
P
P
Colvill
L
L
Davern
P
P
Denton
D A
DA
Oldfield
B J
BJ
Weisinger
R S
RS
Rauch
M
M
Schmid
H A
HA
McKinley
M J
MJ
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D004327:Drinking Behavior / Q000187:drug effects / Q000502:physiology*; D004558:Electric Stimulation; D005260:Female; D016762:Genes, fos; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000494:pharmacology; D012065:Relaxin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D013356:Subfornical Organ / Q000187:drug effects / Q000502:physiology*; D013894:Thirst; D014882:Water-Electrolyte Balance
D011994:Recombinant Proteins; D000804:Angiotensin II; D012065:Relaxin